Arrowhead Pharmaceuticals, Inc. – Consensus ‘buy’ rating and 70.7% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Arrowhead Pharmaceuticals, Inc. which can be found using ticker (ARWR) now have 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 90 and 27 and has a mean target at $61.93. Given that the stocks previous close was at $36.28 this indicates there is a potential upside of 70.7%. Also worth taking note is the 50 day moving average now sits at $30.89 while the 200 day moving average is $34.01. The company has a market cap of 3.88B. The current stock price for Wyndham Hotels & Resorts, Inc. is currently 36.27 USD

The potential market cap would be $6,618,492,393 based on the market consensus.

USD

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 2.57 and a -11.81% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search